Advanced Resin Therapeutics Overview
- Founded
- 1999
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Later Stage VC
- (Cancelled)
- Latest Deal Amount
- $2.5M
- Investors
- 2
Advanced Resin Therapeutics General Information
Description
Operator of a specialty pharmaceutical company intended to conduct research and development of a resin, trans-mucosal systemic delivery of active ingredients focused on the central nervous system. The company's formulations are designed to provide quick delivery of alprazolam for anxiety, ondansetron for nausea, sumatriptan for migraines, fentanyl for pain, Vardenafil and Sildenafil for erectile dysfunction and nicotine as an aid to smoking cessation, providing medical practitioners with a delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies.
Contact Information
Website
www.advancedresin.com
Formerly Known As
Jaleva Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 13073 Signature Point
- Suite 202
- San Diego, CA 92130
- United States
+1 (858) 000-0000
Advanced Resin Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | $2.5M | Cancelled | Generating Revenue | |||
| 3. Later Stage VC (Series 1) | 03-Apr-2017 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Accelerator/Incubator | 12-May-2016 | $454K | Completed | Generating Revenue | ||
| 1. Later Stage VC | 27-May-2011 | $454K | $454K | Completed | Generating Revenue |
Advanced Resin Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Advanced Resin Therapeutics Executive Team (5)
Advanced Resin Therapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alex Battaglia Ph.D | Advanced Resin Therapeutics | Co-Founder, Chief Science Officer & Board Member | 000 0000 |
Advanced Resin Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAdvanced Resin Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CONNECT (Accelerator) | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Button Capital | Venture Capital | Minority | 000 0000 | 000000 0 |